Investar Holding Corporation Announces 2026 Third Quarter Results

Investar reported Q3 2026 diluted EPS of $0.74, up from $0.61 in Q2 and $0.54 a year earlier; core diluted EPS was $0.77. Net interest margin increased 6 bps sequentially to 3.73%, while net income available to common shareholders rose to $11.1 million from $8.9 million in Q2. Nonperforming loans edged up to 0.70% of total loans from 0.63% in Q2; the company also repurchased 25,113 shares at an average $29.44 per share.

Analysis

The earnings quality is less strong than the headline sequential EPS step-up suggests: acquired-loan accretion contributed $3.0 million, while adjusted NIM excluding accretion and recoveries expanded only 1 bp quarter over quarter. Core diluted EPS rose just 2.7%, and the core efficiency ratio edged worse despite lower reported expenses as WFB conversion costs faded. The key test is whether new C&I production and deposit franchise gains can replace finite purchase-accounting accretion without renewed expense creep.

The balance-sheet remix has asymmetric rate exposure. More variable-rate C&I can support asset yields if rates stay higher, but would reprice downward if rates fall; deposit costs may lag in either direction. Meanwhile, sequential deposit contraction alongside higher FHLB advances suggests the shift away from expensive brokered funding is not yet equivalent to durable, low-cost core funding. Commercial bankers are an investment in future relationships, but hiring adds costs before loan and treasury-management revenue arrives—watch production per banker, not just loan growth.

Credit is the main near-term offset: NPLs rose, coverage fell, and growth in acquired 1–4 family exposure complicates the stated de-risking narrative. This is not yet evidence of broad deterioration, but a reversal in the benign credit-cost contribution would expose earnings sensitivity. Over 6–18 months, successful integration and C&I mix improvement could support returns; persistent deposit leakage, worsening home-loan delinquencies, or falling adjusted NIM would invalidate that case. With no valuation or post-release price context, avoid treating this as an unconditional earnings-momentum buy.

Key Decisions for Investors

• Do not chase the reported EPS beat at the open. Consider a small relative long ISTR versus KRE only on weakness and after checking valuation; use the next quarter as a confirmation point rather than assuming acquisition synergies are proven.
• Set a catalyst watch for adjusted NIM ex-accretion, core efficiency ratio, and deposit balances/costs. A further decline in adjusted NIM or continued deposit shrinkage funded by increased FHLB advances would invalidate the improving-franchise thesis.
• Track credit by category, especially acquired 1–4 family delinquencies and nonperforming loans, alongside allowance coverage. A sustained rise in NPLs or materially higher provision expense is a reason to exit or avoid the relative long.
• Monitor C&I production and banker productivity against compensation growth. If loan growth fails to translate into core spread income and fee relationships over the next 1–3 quarters, the expense base may outrun the benefits of the portfolio remix.